Trial intelligence / Profile preview

Simvastatin and sputum conversion in pulmonary tuberculosis

TCTR20180219002Phase 3Not yet recruiting

Sponsor
Thammasorn Jeeraaumponwat
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in pulmonary tuberculosis (TB), sponsored by Thammasorn Jeeraaumponwat. Planned start Apr 2018; status: not yet recruiting.

02

Drugs

simvastatin
03

Conditions

pulmonary tuberculosis (TB)

Beyond the preview

Go deeper on TCTR20180219002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180219002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call